These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 25386730)
1. Effects of titanium dioxide nanoparticles on α-synuclein aggregation and the ubiquitin-proteasome system in dopaminergic neurons. Wu J; Xie H Artif Cells Nanomed Biotechnol; 2016; 44(2):690-4. PubMed ID: 25386730 [TBL] [Abstract][Full Text] [Related]
3. Effects of titanium dioxide nanoparticles exposure on parkinsonism in zebrafish larvae and PC12. Hu Q; Guo F; Zhao F; Fu Z Chemosphere; 2017 Apr; 173():373-379. PubMed ID: 28129614 [TBL] [Abstract][Full Text] [Related]
4. Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation. Cai CZ; Zhou HF; Yuan NN; Wu MY; Lee SM; Ren JY; Su HX; Lu JJ; Chen XP; Li M; Tan JQ; Lu JH Phytomedicine; 2019 Aug; 61():152842. PubMed ID: 31048127 [TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein aggregation, Ubiquitin proteasome system impairment, and L-Dopa response in zinc-induced Parkinsonism: resemblance to sporadic Parkinson's disease. Kumar V; Singh D; Singh BK; Singh S; Mittra N; Jha RR; Patel DK; Singh C Mol Cell Biochem; 2018 Jul; 444(1-2):149-160. PubMed ID: 29198021 [TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-proteasome system and Parkinson's diseases. Betarbet R; Sherer TB; Greenamyre JT Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways. Anandhan A; Rodriguez-Rocha H; Bohovych I; Griggs AM; Zavala-Flores L; Reyes-Reyes EM; Seravalli J; Stanciu LA; Lee J; Rochet JC; Khalimonchuk O; Franco R Neurobiol Dis; 2015 Sep; 81():76-92. PubMed ID: 25497688 [TBL] [Abstract][Full Text] [Related]
8. α-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation. Chen JY; Zhu Q; Cai CZ; Luo HB; Lu JH Phytomedicine; 2022 Jul; 101():154125. PubMed ID: 35525236 [TBL] [Abstract][Full Text] [Related]
9. Dieldrin induces ubiquitin-proteasome dysfunction in alpha-synuclein overexpressing dopaminergic neuronal cells and enhances susceptibility to apoptotic cell death. Sun F; Anantharam V; Latchoumycandane C; Kanthasamy A; Kanthasamy AG J Pharmacol Exp Ther; 2005 Oct; 315(1):69-79. PubMed ID: 15987830 [TBL] [Abstract][Full Text] [Related]
10. Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein. McKinnon C; De Snoo ML; Gondard E; Neudorfer C; Chau H; Ngana SG; O'Hara DM; Brotchie JM; Koprich JB; Lozano AM; Kalia LV; Kalia SK Acta Neuropathol Commun; 2020 Feb; 8(1):17. PubMed ID: 32059750 [TBL] [Abstract][Full Text] [Related]
11. [Impacts of electroacupuncture on ubiquitin-proteasome system in rats with Parkinson's disease]. Wang YC; He F; Ma J; Zhou D; Liang Y; Gong YX Zhongguo Zhen Jiu; 2013 Aug; 33(8):725-9. PubMed ID: 24195216 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Protein Ubiquitination by Paraquat and 1-Methyl-4-Phenylpyridinium Impairs Ubiquitin-Dependent Protein Degradation Pathways. Navarro-Yepes J; Anandhan A; Bradley E; Bohovych I; Yarabe B; de Jong A; Ovaa H; Zhou Y; Khalimonchuk O; Quintanilla-Vega B; Franco R Mol Neurobiol; 2016 Oct; 53(8):5229-51. PubMed ID: 26409479 [TBL] [Abstract][Full Text] [Related]
13. [The role of parkin in Parkinson's disease]. Miklya I; Göltl P; Hafenscher F; Pencz N Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049 [TBL] [Abstract][Full Text] [Related]
14. Icariin reduces α-synuclein over-expression by promoting α-synuclein degradation. Zhang L; Shen C; Chu J; Liu Y; Li Y; Zhang L; Li L Age (Dordr); 2015 Aug; 37(4):9811. PubMed ID: 26169945 [TBL] [Abstract][Full Text] [Related]
15. α-Synuclein Enhances Cadmium Uptake and Neurotoxicity via Oxidative Stress and Caspase Activated Cell Death Mechanisms in a Dopaminergic Cell Model of Parkinson's Disease. Chong W; Jiménez J; McIIvin M; Saito MA; Kwakye GF Neurotox Res; 2017 Aug; 32(2):231-246. PubMed ID: 28353032 [TBL] [Abstract][Full Text] [Related]
17. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions. Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575 [TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibition and aggregation in Parkinson's disease: a comparative study in untransfected and transfected cells. Biasini E; Fioriti L; Ceglia I; Invernizzi R; Bertoli A; Chiesa R; Forloni G J Neurochem; 2004 Feb; 88(3):545-53. PubMed ID: 14720204 [TBL] [Abstract][Full Text] [Related]
19. TNF compromises lysosome acidification and reduces α-synuclein degradation via autophagy in dopaminergic cells. Wang MX; Cheng XY; Jin M; Cao YL; Yang YP; Wang JD; Li Q; Wang F; Hu LF; Liu CF Exp Neurol; 2015 Sep; 271():112-21. PubMed ID: 26001614 [TBL] [Abstract][Full Text] [Related]
20. [Parkinson's disease: what have we learned from the genes responsible for familial forms?]. Corti O; Brice A Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]